There May Be Underlying Issues With The Quality Of Windlas Biotech's (NSE:WINDLAS) Earnings
Nov 20
Have your own idea? Try our Stock Screener
Indian (NIFTY) Life Sciences Industry Analysis
UpdatedNov 20, 2024
DataAggregated Company Financials
Companies17
- 7D-0.3%
- 3M11.0%
- 1Y47.9%
- YTD37.7%
The Life Sciences industry has been flat over the last week, but Syngene International has lost 4.3%. As for the the longer term, the industry is up 48% over the past 12 months. As for the next few years, earnings are expected to grow by 23% per annum.
Industry Valuation and Performance
Has the Indian Life Sciences Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 21 Nov 2024 | ₹2.3t | ₹254.1b | ₹28.8b | 45.1x | 81.3x | 9.2x |
| Sat, 19 Oct 2024 | ₹2.4t | ₹247.6b | ₹26.3b | 52.8x | 92.9x | 9.9x |
| Mon, 16 Sep 2024 | ₹2.3t | ₹247.6b | ₹26.3b | 51.9x | 88.5x | 9.4x |
| Wed, 14 Aug 2024 | ₹1.9t | ₹206.4b | ₹24.8b | 35.1x | 77.3x | 9.3x |
| Fri, 12 Jul 2024 | ₹1.8t | ₹202.0b | ₹23.9b | 38.8x | 75.4x | 8.9x |
| Sun, 09 Jun 2024 | ₹1.7t | ₹194.7b | ₹21.5b | 33x | 80.2x | 8.9x |
| Tue, 07 May 2024 | ₹1.5t | ₹167.8b | ₹18.7b | 29.5x | 77.9x | 8.7x |
| Thu, 04 Apr 2024 | ₹1.4t | ₹168.5b | ₹18.6b | 29.3x | 75.6x | 8.3x |
| Sat, 02 Mar 2024 | ₹1.4t | ₹168.5b | ₹18.6b | 32.1x | 72.8x | 8x |
| Mon, 29 Jan 2024 | ₹1.4t | ₹166.5b | ₹18.9b | 30.5x | 72.1x | 8.2x |
| Wed, 27 Dec 2023 | ₹1.4t | ₹155.9b | ₹18.1b | 21.7x | 77.5x | 9x |
| Fri, 24 Nov 2023 | ₹1.4t | ₹155.9b | ₹18.1b | 22.8x | 75.7x | 8.8x |
| Sun, 22 Oct 2023 | ₹1.3t | ₹156.1b | ₹19.8b | 26.2x | 66.4x | 8.4x |
| Tue, 19 Sep 2023 | ₹1.4t | ₹154.7b | ₹19.7b | 24.8x | 72x | 9.2x |
| Thu, 17 Aug 2023 | ₹1.4t | ₹154.7b | ₹19.7b | 23.9x | 71x | 9x |
| Sat, 15 Jul 2023 | ₹1.4t | ₹156.5b | ₹23.0b | 31.3x | 59.7x | 8.8x |
| Mon, 12 Jun 2023 | ₹1.3t | ₹157.3b | ₹23.0b | 27.7x | 55.6x | 8.1x |
| Wed, 10 May 2023 | ₹1.3t | ₹163.0b | ₹28.7b | 33.7x | 43.8x | 7.7x |
| Fri, 07 Apr 2023 | ₹1.1t | ₹159.5b | ₹28.4b | 32.4x | 38.6x | 6.9x |
| Sun, 05 Mar 2023 | ₹1.1t | ₹159.5b | ₹28.4b | 31.6x | 37.5x | 6.7x |
| Tue, 31 Jan 2023 | ₹1.2t | ₹166.4b | ₹34.5b | 29.9x | 34.7x | 7.2x |
| Thu, 29 Dec 2022 | ₹1.2t | ₹164.9b | ₹34.5b | 30.6x | 35.7x | 7.5x |
| Sat, 26 Nov 2022 | ₹1.2t | ₹164.9b | ₹34.5b | 29.7x | 35.3x | 7.4x |
| Mon, 24 Oct 2022 | ₹1.3t | ₹164.1b | ₹36.1b | 35.6x | 35.1x | 7.7x |
| Wed, 21 Sep 2022 | ₹1.3t | ₹162.5b | ₹35.7b | 37.8x | 35.9x | 7.9x |
| Fri, 19 Aug 2022 | ₹1.3t | ₹162.6b | ₹35.8b | 36.5x | 36.9x | 8.1x |
| Sun, 17 Jul 2022 | ₹1.3t | ₹158.3b | ₹34.2b | 33.4x | 38.7x | 8.4x |
| Tue, 14 Jun 2022 | ₹1.2t | ₹158.3b | ₹34.2b | 31.2x | 35.7x | 7.7x |
| Thu, 12 May 2022 | ₹1.4t | ₹150.1b | ₹30.1b | 32.9x | 47.7x | 9.6x |
| Sat, 09 Apr 2022 | ₹1.6t | ₹148.3b | ₹29.4b | 39.4x | 53x | 10.5x |
| Mon, 07 Mar 2022 | ₹1.4t | ₹148.3b | ₹29.4b | 35x | 47.6x | 9.4x |
| Wed, 02 Feb 2022 | ₹1.4t | ₹138.5b | ₹24.6b | 39x | 58.4x | 10.3x |
| Fri, 31 Dec 2021 | ₹1.6t | ₹137.8b | ₹24.6b | 33.4x | 64.4x | 11.5x |
| Sun, 28 Nov 2021 | ₹1.7t | ₹137.6b | ₹24.4b | 31.7x | 68.3x | 12.1x |
Price to Earnings Ratio
68.3x
Current Industry PE
- Investors are optimistic on the Indian Life Sciences industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 81.3x which is higher than its 3-year average PE of 58.8x.
- The industry is trading close to its 3-year average PS ratio of 8.7x.
Past Earnings Growth
- The earnings for companies in the Life Sciences industry have grown 5.7% per year over the last three years.
- Revenues for these companies have grown 23% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the Indian Healthcare industry?
| IN Market | -1.80% | |
| Healthcare | -1.79% | |
| Life Sciences | -0.28% | |
| Clinical Research and Equipment | -0.28% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| DIVISLAB Divi's Laboratories | ₹5.90k | 2.3% +₹34.7b | 59.4% | PE85.3x | |
| DCAL Dishman Carbogen Amcis | ₹220.01 | 23.0% +₹6.4b | 26.7% | PS1.3x | |
| 544184 Borosil Scientific | ₹181.15 | 2.3% +₹368.9m | n/a | PE55.8x | |
| BROOKS Brooks Laboratories | ₹141.48 | 5.8% +₹203.4m | 10.0% | PS4.7x | |
| 511509 Vivo Bio Tech | ₹39.98 | 18.6% +₹93.3m | 23.1% | PE8x |